Prevalence of AOX1 and CYP1A2 gene polymorphisms associated with response to favipiravir therapy in novel coronavirus infection COVID-19 among ethnic groups of the North Caucasus

Prevalence of AOX1 and CYP1A2 gene polymorphisms associated with response to favipiravir therapy in novel coronavirus infection COVID-19 among ethnic groups of the North Caucasus

Drug sensitivity to, in particular to favipiravir, may vary among representatives of different ethnic groups. Studies have previously shown that carrying certain variants of the AOX1 and CYP1A2 genes may be associated with an increased incidence of adverse reactions with patients having COVID-19 and...

Full description

Saved in:
Bibliographic Details
Main Authors: A. T. Leinsoo, N. P. Denisenko, Sh. P. Abdullaev, S. N. Tuchkova, A. V. Kryukov, S. N. Mammaev, Zh. A. Sozaeva, M. S.-Kh. Sozaeva, K. A. Akmalova, L. Z. Bolieva, A. I. Dobroselskaya, M. L. Maksimov, K. B. Mirzaev, D. A. Sychev
Format: Article
Language:Russian
Published: Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute 2025-07-01
Series:Фармация и фармакология (Пятигорск)
Subjects:
favipiravir
covid-19
ethnic groups
aox1
cyp1a2
Online Access:https://www.pharmpharm.ru/jour/article/view/1670
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.pharmpharm.ru/jour/article/view/1670

Similar Items